Exclusive content for medical professionals and students.
Food for a diabetes diet can include meal replacements in the form of oral nutritional supplements (ONS) for weight management and post-meal blood glucose control. In practice, ONS have been extensively prescribed in medical nutrition therapy. Recently, clinical studies comparing standard ONS vs. diabetes-specific ONS (DS-ONS) have all confirmed DS-ONS are superior for T2D patients. The science behind this special diabetes food is based on a balance of macronutrients designed to meet the needs of patients with diabetes. Specifically, DS-ONS formulations have been developed with more proteins, less carbohydrates, and more fiber. This article provides a summary of clinical studies that demonstrate the evidence-based outcomes of DS-ONS in diabetes patients.1-4
Scientific evidence is continuously in favor of special diabetes food such as the DS-ONS in controlling glycemia in T2D patients. DS-ONS have shown superiority compared to normal ONS and usual meals. How can DS-ONS help T2D patients? DS-ONS better reduce postprandial glucose levels, enhance sensitivity to insulin, and enhance metabolic status in the long term. The following is a review of key clinical study results on DS-ONS.1-4
This was a randomized crossover trial involving 12 participants. The aim was to compare DS-ONS (BOOST Glucose Control) with a standard ONS.1 The demographics of participants and the nutritional composition of both formulas in this study are illustrated in figures 1 and 2:
Figure 2 nutritional composition of the two formulas used in the klosterbuer study
(TE = Total Energy)
Note: The original study included separate comparisons of two DS-ONS formulations vs. control. As one formulation is no longer commercially available, this summary was simplified to include only the existing DS-ONS
In sum, the Klosterbuer A, et al. study confirms that DS-ONS can help reduce blood sugar spikes and improve glycemic control in T2DM patients, supporting their integration into clinical care.1
In this study, Huhmann et al. investigated the role of a diabetes-specific ONS (BOOST Glucose Control) vs. a standard ONS (BOOST Original) in a randomized crossover trial:
Figure 4 Participants' demographics in huhmann MB et al. study
The mean glucose AUC was significantly lower in the DS-ONS group compared with standard ONS (p<0.0001).
(standard ONS and diabetes-specific ONS).
There was no significant difference observed for mean insulin AUC (p=0.068). A sensitivity analysis of the mean insulin AUC measures was performed to identify any potential outliers. One outlier was identified, which was observed to have an insulin AUC value more than twice as high as the next highest value. Thus, this value was removed from analyses, resulting in a significant difference between the groups (p=0.012).
(standard ons vs diabetes-specific ons)
In conclusion, the Huhmann MB, et al. study findings further support the use of DS-ONS for stabilizing postprandial glucose levels and reducing glycemic variability in T2D patients.
In this study, Gulati et al. compared a DS-ONS (NUTREN Diabetes) with an isocaloric meal of cornflakes and milk in a randomized crossover trial.3
The study enrolled a total of 40 participants with T2DM, divided into two groups. Baseline characteristics, such as weight and HbA1c levels, were similar between both groups.
Figure 10 shows the AUC for blood glucose post-meal at 30 min, 60 min, 120 min, and 180 min was significantly lower for Group A as compared with Group B (p = 0.003, 0.0001, 0.0001, and 0.0001, respectively).
Figure 11 area under curve (AUC) for serum insulin in group a and ggroup b
In sum, the Gulati et al. study findings reinforce the role of DS-ONS in achieving better glycemic control as an effective approach to controlling postprandial hyperglycemia, further substantiating their use in medical nutrition therapy.
This was a randomized, open-label, crossover study conducted at Ramathibodi Hospital, Mahidol University, Thailand. Thirty patients with T2D participated in the study, receiving either a DS-ONS NUTREN Diabetes (Group A) or a standard isocaloric diet (Group B) in the first phase. After a one-week washout period, the groups switched interventions.4
Composition of the test meal and the diabetes-specific formula (DSF) in the Phanachet et al. study4
1- Postprandial hyperglycemia (PPH) levels in the DS-ONS (NUTREN Diabetes) group were significantly lower than those in the isocaloric diet group at 120 minutes (161.4 ± 37.9 mg/dL vs. 197.7 ± 56.8 mg/dL; P=0.005)4
The incremental area under the curve (iAUC) for glucose was significantly lower for DS-ONS (NUTREN Diabetes) compared to the standard diet (4,859.5 vs. 6,551.7; P=0.007)4
All the outcomes of these large clinical trials affirm DS-ONS as an evidence-based medical nutrition therapy in T2D care. By lowering postprandial glucose levels, reducing glycemic variability, and preserving metabolic health, DS-ONS represent a practical nutritional solution for t2D patients. DS-ONS, unlike standard ONS, comprise lower glycemic index complex carbohydrates, more protein, and more micronutrients to meet the needs of diabetes patients.1-4
Learn more about
Intensive Lifestyle Interventions in Obesity and Diabetes.
This article presents the science behind special diabetes food. Diabetes-specific oral nutrition supplements, which consist of a tailored macronutrient composition have proven efficacy for glycemic control. Discover an overview of posters and publications of large clinical trials comparing DS-ONS vs. standard ONS in type 2 diabetes patients. Evidenced-based outcomes support integration of DS-ONS in medical nutrition care for diabetes patients.
ARTICLE
Managing blood sugar levels through non-drug therapies is possible and is backed by science and clinical studies. The EASD 2021 and 2022 symposiums highlighted how non-pharmacological strategies, like whey protein and Morus Alba extract, can help regulate post-prandial glycemia. Learn more about the importance of addressing PPH in type 2 diabetes and the clinical study results supporting the use of non-pharmacological and natural nutritional therapies.
Can type 2 diabetes be cured ? The answer is yes. Type 2 diabetes is traditionally recognized as a chronic disease that needs lifelong treatment. Yet, new evidence now shows remission is possible using an evidence-based nutritional and weight loss approach. Learn more about the clinical results of structured weight loss program based on the DiRECT and DiRECT-Aus studies.
Whey protein (WP) is a nutritional and non-pharmacological diabetes therapy. In fact, WP has emerged as a powerful supplement for diabetes, particularly in controlling postprandial hyperglycemia (PPH). Backed by evidence from clinical trials, whey protein has unique mechanism of action that can reduce PPH levels, improve glycemic control in type 2 diabetes patients.
In type 2 diabetes nutrition, a low carb diabetes diet has emerged as a recommended strategy. Accordingly, diabetes-specific nutritional formulas (DSNFs) are formulated with optimized macronutrient compositions that take into account the latest diabetes nutritional strategies. Both low carbohydrate diets and DSNFs aim to stabilize blood glucose levels and enhance insulin sensitivity. Find out more about these interventions.
Special diabetes food in diabetes nutrition includes the scientifically proven Diabetes-Specific Nutrition Formulas (DSNFs). DSNFs offer a non-pharmacological evidence-based diabetes therapy by providing a well-balanced macronutrient distribution, low-GI carbohydrates, and essential micronutrients. Learn more about the benefits of DSNFs vs standard nutrition formulas.
Obesity is considered as one of the common triggers for the development of type 2 diabetes. As a result, a diabetes diet for weight loss that is aligned with the most updated diabetes nutrition guidelines, can help manage diabetes effectively. Learn more about the latest guideline on the most effective nutritional diabetes management.
Based on the International Diabetes Federation (IDF) statistics, nearly half of all adults with diabetes worldwide remain undiagnosed. This is equivalent to around 239.7 million people unaware of their condition. Particularly in South-East Asia undiagnosed diabetes rates exceed 50%. Learn more about solutions for this problem and how diabetes-specific formulas can help your patients control their blood glucose.
Breakfast has a non-pharmacological role in managing type 2 diabetes, influencing glycemic control, insulin responses, and overall metabolic health. This article explores how breakfast composition, particularly the balance of carbohydrates, proteins, and fats, affects blood sugar regulation. It highlights recent studies comparing the impact of low-carbohydrate, high-protein breakfasts with traditional low-fat options.
Whey protein is well-known for its role as a non-pharmacological supplement for managing blood sugar levels, but did you know about its role in a heart healthy diabetes diet? This article sheds light on findings from 22 randomized controlled trials (RCTs) involving over 1,100 participants, highlighting how whey protein can benefit the overall lipid profile and heart health.
How does diabetes nutrition education with intensive lifestyle interventions impact diabetes patient outcomes in the realworld setting? Strong evidence now supports intensive lifestyle interventions that include a weight loss diet and exercise for diabetes. Learn more about The Look AHEAD study (Action for Health in Diabetes) and Why WAIT program (Weight Achievement and Intensive Treatment) results that demonstrated the efficacy of structured lifestyle interventions in managing diabetes.
Precision nutrition in diabetes diets can help healthcare professionals come up with individualized diet plans based on metabolic, genetic, and behavioral factors. Studies identify a large heterogeneity of responses to foods, which contradicts the rationale for the same dietary guidance for all patients. Learn more about this innovative approach in the nutritional management of diabetes patients.
This article will highlight some of the topics discussed in the 39th International Symposium on Diabetes and Nutrition. We will present topics about prevention and treatment of diabetes with nutrition and lifestyle. The article will present updated information about remission of diabetes through weight loss, timely intervention in prediabetes and precision nutrition’s role in cardiometabolic health.
You can share this content on your preferred social networks.
Login or Register to have access to all the exclusive content
Login or register and you will be able to favorite articles, videos and many exclusive contents by saving the list in My favorites